Asebogenin suppresses thrombus formation via inhibition of Syk phosphorylation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asebogenin suppresses thrombus formation via inhibition of
Syk
phosphorylation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-09-28
DOI
10.1111/bph.15964
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-Thrombotic Effects Mediated by Dihydromyricetin Involve Both Platelet Inhibition and Endothelial Protection
- (2021) Shuai Chen et al. PHARMACOLOGICAL RESEARCH
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation
- (2021) Jiaxin Zhao et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology : Reproducibility of natural product research
- (2020) Angelo A. Izzo et al. BRITISH JOURNAL OF PHARMACOLOGY
- ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
- (2020) Elliott Lilley et al. BRITISH JOURNAL OF PHARMACOLOGY
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro
- (2020) Yuan yuan Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases
- (2020) Maan H. Harbi et al. PLATELETS
- Neutrophil Extracellular Traps in Arterial and Venous Thrombosis
- (2019) Elodie Laridan et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Antithrombotic Agents
- (2019) Noel C. Chan et al. CIRCULATION RESEARCH
- The search for new antithrombotic mechanisms and therapies that may spare hemostasis
- (2018) Edward F. Plow et al. BLOOD
- Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
- (2018) Steve P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mollebenzylanols A and B, Highly Modified and Functionalized Diterpenoids with a 9-Benzyl-8,10-dioxatricyclo[5.2.1.01,5]decane Core from Rhododendron molle
- (2018) Junfei Zhou et al. ORGANIC LETTERS
- Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis
- (2018) Astrid S. Clarke et al. THROMBOSIS RESEARCH
- Physiological Stimuli Induce PAD4-Dependent, ROS-Independent NETosis, With Early and Late Events Controlled by Discrete Signaling Pathways
- (2018) Olga Tatsiy et al. Frontiers in Immunology
- Differential Signalling and Kinetics of Neutrophil Extracellular Trap Release Revealed by Quantitative Live Imaging
- (2017) Maarten van der Linden et al. Scientific Reports
- Syk Inhibition in Ischemic Stroke
- (2016) Steven E. McKenzie ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The Novel Oral Syk Inhibitor, Bl1002494, Protects Mice From Arterial Thrombosis and Thromboinflammatory Brain InfarctionHighlights
- (2016) Judith M.M. van Eeuwijk et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Emerging anticoagulant strategies
- (2016) James C. Fredenburgh et al. BLOOD
- Global Burden of Thrombosis: Table.
- (2016) Aaron M. Wendelboe et al. CIRCULATION RESEARCH
- Tyrosine kinase signaling pathways in neutrophils
- (2016) Krisztina Futosi et al. IMMUNOLOGICAL REVIEWS
- Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder
- (2016) Yangyang Bian et al. Nature Chemical Biology
- Assessment of Venous Thrombosis in Animal ModelsSignificance
- (2015) Steven P. Grover et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Venous thrombosis
- (2015) Alisa S. Wolberg et al. Nature Reviews Disease Primers
- Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase
- (2014) Kevin S. Currie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-influenza A virus activity of a new dihydrochalcone diglycoside isolated from the Egyptian seagrassThalassodendron ciliatum(Forsk.) den Hartog
- (2014) Magdy M.D. Mohammed et al. NATURAL PRODUCT RESEARCH
- Role of Focal Adhesion Tyrosine Kinases in GPVI-Dependent Platelet Activation and Reactive Oxygen Species Formation
- (2014) Naadiya Carrim et al. PLoS One
- Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation
- (2013) C. Fang et al. BLOOD
- Thrombosis: tangled up in NETs
- (2013) K. Martinod et al. BLOOD
- Off-targets effects underlie the inhibitory effect of FAK inhibitors on platelet activation: studies usingFak-deficient mice
- (2013) M. E. Roh et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Chemical and antifungal investigations of six Lippia species (Verbenaceae) from Brazil
- (2012) Cristiano Soleo Funari et al. FOOD CHEMISTRY
- Superbinder SH2 Domains Act as Antagonists of Cell Signaling
- (2012) T. Kaneko et al. Science Signaling
- Critical role for Syk in responses to vascular injury
- (2011) P. Andre et al. BLOOD
- Arterial thrombosis—insidious, unpredictable and deadly
- (2011) Shaun P Jackson NATURE MEDICINE
- Signaling During Platelet Adhesion and Activation
- (2010) Zhenyu Li et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- GPVI and CLEC-2 in hemostasis and vascular integrity
- (2010) S. P. WATSON et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
- (2009) F. May et al. BLOOD
- Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation
- (2009) Laura Carsetti et al. CELLULAR SIGNALLING
- The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets
- (2009) J. C. SPALTON et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role
- (2009) Alec A. Schmaier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now